ALR TECHNOLOGIES INCORPORATED (OTCMKTS:ALRT) Can’t Be More Risky. Short Interest Increased

January 11, 2018 - By Nellie Frank

The stock of ALR TECHNOLOGIES INCORPORATED (OTCMKTS:ALRT) registered an increase of 5865% in short interest. ALRT’s total short interest was 119,300 shares in January as published by FINRA. Its up 5865% from 2,000 shares, reported previously. With 516,200 shares average volume, it will take short sellers 0 days to cover their ALRT’s short positions.

The stock increased 0.32% or $0.0001 during the last trading session, reaching $0.0313. About 183,904 shares traded. ALR Technologies Inc. (OTCMKTS:ALRT) has 0.00% since January 11, 2017 and is . It has underperformed by 16.70% the S&P500.

ALR Technologies Inc. develops compliance monitoring systems that enable health care professionals to monitor patient health conditions and provide patient health management in the United States. The company has market cap of $7.60 million. The companyÂ’s product includes Health-e-Connect System, which consists of a communications software platform that enables health professionals to monitor the health progress relating to patients with diabetes. It currently has negative earnings. It focuses on marketing its products primarily to the providers of health insurance; and the providers of disease and case management services, including the home care industry.

More important recent ALR Technologies Inc. (OTCMKTS:ALRT) news were published by: Seekingalpha.com which released: “FDA OKs ALR’s insulin dosing adjustment feature on diabetes management system” on September 19, 2017, also Marketwatch.com published article titled: “ALR Technologies Inc.”, Globenewswire.com published: “ALR Technologies Signs First Revenue-Generating Contract” on April 20, 2015. More interesting news about ALR Technologies Inc. (OTCMKTS:ALRT) was released by: Marketwired.com and their article: “The Kansas City Metropolitan Physician Association and ALR Technologies …” with publication date: July 29, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.